Recap: Arbutus Biopharma Q2 Earnings


Arbutus Biopharma ABUS reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


Arbutus Biopharma beat estimated earnings by 23.08%, reporting an EPS of $-0.1 versus an estimate of $-0.13.

Revenue was up $11.91 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 0.78% drop in the share price the next day.

Here's a look at Arbutus Biopharma's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.16 -0.19 -0.24 -0.22
EPS Actual -0.11 -0.15 -0.24 -0.23
Revenue Estimate 4.37M 2.87M 2.38M 2.12M
Revenue Actual 12.58M 3.21M 3.34M 2.33M

To track all earnings releases for Arbutus Biopharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings




Posted In: EarningsNewsBZI-Recaps